4 things that worry FDA Commissioner Robert Califf

The latest stories trending on MedCity News.

Editor's Pick

Top Story 4 Things That Worry FDA Commissioner Robert Califf This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such as his worry that AI is worsening health inequities and his concern that providers aren't capable of validating AI tools' effectiveness.

Featured News

Gates Foundation Joins Radiant Bio's $35M Round for Antibody Drugs With 'Better Grip' Radiant Biotherapeutics' Multabodies are antibodies engineered to offer better binding strength to their targets. The preclinical startup's lead program goes after a cancer immunotherapy target being pursued by several biotech companies already in early clinical development. How To Spot Deepfakes and Other Cybersecurity Panel Takeaways from HLTH Two chief information security officers offer some advice at a cybersecurity panel at HLTH. Video: Was Carrum's CEO the Voice of Reason at HLTH? Sach Jain, the CEO of Carrum Health, which helps self-insured employers manage their surgical care costs, had a sobering perspective at HLTH, a conference that celebrates innovation in healthcare. The Convergence of Digital Health and Life Sciences Despite the challenges of interoperability, regulatory compliance, technology adoption, and data privacy, the benefits of digital health are undeniable. Collaboration between policymakers, clinicians, IT developers, and patients, can help overcome these obstacles. Targeting the Blast Radius: Why Spatial AI Diagnostics Are Crucial for Maximizing the Impact of Antibody-Drug Conjugates As the field of oncology evolves, we need to shift away from traditional binary "yes-no" biomarkers to a more nuanced, spatial understanding of tumor biology. This approach will allow for more personalized treatment plans that are tailored to the unique characteristics of each patient's tumor.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 9 In this episode, we talk about virtual care and how Dr. Eve Cunningham approaches technology to scale remote care programs to help physicians managing chronic disease patients. We also address how the Federal Trade Commission is suing the three largest pharmacy benefit managers for their role in keeping insulin prices high when lower priced insulin was already available. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe